Type 1 diabetes immunotherapy using polyclonal regulatory T cells

Type 1 diabetes (T1D) is an autoimmune disease that occurs in genetically susceptible individuals. Regulatory T cells (Tregs) have been shown to be defective in the autoimmune disease setting. Thus, efforts to repair or replace Tregs in T1D may reverse autoimmunity and protect the remaining insulin-...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Transl Med
Hlavní autoři: Bluestone, Jeffrey A., Buckner, Jane H., Fitch, Mark, Gitelman, Stephen E., Gupta, Shipra, Hellerstein, Marc K., Herold, Kevan C., Lares, Angela, Lee, Michael R., Li, Kevin, Liu, Weihong, Long, S. Alice, Masiello, Lisa M., Nguyen, Vinh, Putnam, Amy L., Rieck, Mary, Sayre, Peter, Tang, Qizhi
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4729454/
https://ncbi.nlm.nih.gov/pubmed/26606968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aad4134
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky